前列腺癌肾上腺转移的特征:依赖雄激素受体信号传导与类固醇激素
该研究回顾性分析了3例接受肾上腺切除术的前列腺癌转移患者,并将其中1例肾上腺转移灶建立为异种移植模型MDA-PCa-250。通过外显子测序、RNA测序、免疫组化和类固醇代谢物定量,发现肾上腺转移灶具有活跃的雄激素受体信号,且能将肾上腺雄激素前体转化为睾酮;体外实验显示睾酮和皮质醇可刺激肿瘤细胞生长,体内实验显示MDA-PCa-250在完整小鼠中生长而在去势小鼠中不生长。结论认为前列腺癌肾上腺转移依赖微环境中雄激素前体驱动的雄激素受体信号。
要点
- 肾上腺转移灶具有活跃的雄激素受体信号,RNA测序支持肾上腺雄激素前体代谢激活雄激素受体。
- 类固醇定量提示肾上腺雄激素前体在转移灶中转化为睾酮,稳定同位素示踪证实其生物合成能力。
- 体外实验显示睾酮和皮质醇刺激肿瘤细胞生长;MDA-PCa-250在完整小鼠中生长,去势小鼠中不生长。
核心结论
- 前列腺癌肾上腺转移依赖微环境中可利用的雄激素前体(雄烯二酮和脱氢表雄酮)驱动的雄激素受体信号,尽管存在异质性体细胞DNA改变。
- MDA-PCa-250提供了可再现肾上腺转移独特雄激素依赖性的临床前模型。
研究设计与样本
- 回顾性识别3例有肾上腺切除术存档肿瘤组织的转移性前列腺癌患者,并将1例肾上腺转移灶建立为异种移植模型MDA-PCa-250。
- 对肾上腺转移灶进行体细胞DNA全外显子测序、RNA测序、免疫组化和类固醇代谢物定量。
- 在体外和体内测试类固醇代谢物对肾上腺转移细胞和肿瘤生长的影响。
主要发现
- 临床上,肾上腺切除术在去势抵抗性寡转移疾病期间进行,2例患者对亮丙瑞林重新敏感。
- 体细胞DNA全外显子测序揭示肿瘤抑制基因和DNA损伤修复通路基因的异质性改变。
- 免疫组化显示肾上腺转移灶具有活跃的雄激素受体信号,RNA测序支持肾上腺雄激素前体代谢在激活雄激素受体中的潜在作用。
- 类固醇定量提示肾上腺雄激素前体在这些转移灶中转化为睾酮,MDA-PCa-250来源类器官的稳定同位素示踪证实肾上腺转移灶能够从肾上腺前体生物合成睾酮。
- 体外测试显示睾酮和皮质醇刺激MDA-PCa-250来源细胞系的肿瘤细胞生长;体内实验显示MDA-PCa-250在循环睾酮的完整小鼠中生长,但在去势小鼠中不生长。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prostate cancer (PCa) typically spreads to the bone, and this distribution is attributed to the central role of the microenvironment in progression. However, metastasis to the adrenal glands, while not as common, does occur. The biology that accounts for adrenal metastases may be attributed to the unique local steroid metabolome and co-clinical characterization may elucidate the role steroid biosynthesis plays in PCa progression. METHODS: Three patients with metastatic PCa who had archived tumor tissue from an adrenalectomy were retrospectively identified, and one adrenal metastasis was developed into a xenograft (MDA-PCa-250). The adrenal metastases were characterized by performing somatic DNA whole exome sequencing (WES), RNA-Seq, immunohistochemistry (IHC), and steroid metabolite quantitation. The influence of steroid metabolites on adrenal metastasis cells and tumor growth was tested in vitro and in vivo. RESULTS: Clinically, adrenalectomy was performed during castration-resistant oligometastatic disease, and two men experienced resensitization to leuprolide. Somatic DNA WES revealed heterogeneous alterations in tumor suppressor and DNA damage repair pathway genes. Adrenal metastases had active androgen receptor (AR) signaling by IHC, and RNA-Seq supported a potential role for adrenal androgen precursor metabolism in activating the AR. Steroid quantitation suggested the adrenal androgen precursors were converted into testosterone in these metastases, and stable isotope tracing of an organoid from MDA-PCa-250 confirmed the capability of adrenal metastases to biosynthesize testosterone from adrenal precursors. In vitro testing of a cell line derived from MDA-PCa-250 showed that testosterone and cortisol stimulated tumor cell growth. In vivo experiments demonstrated that MDA-PCa-250 grew in intact mice with circulating testosterone, but not in castrated mice. CONCLUSIONS: PCa adrenal metastases depend upon AR signaling driven by androgen precursors, androstenedione and dehydroepiandrosterone, available in the microenvironment, despite the presence of heterogeneous somatic DNA alterations. Moreover, MDA-PCa-250 provides a preclinical model that can recapitulate the unique androgen-dependence of adrenal metastases. CLINICAL TRIAL REGISTRATION: This study does not report the clinical results of a clinical trial, but it does use samples from a completed clinical trial that is registered with clinicaltrials.gov (NCT01254864).
引用
- Sakellakis MJ, Hahn AW, Ramachandran S, et al. Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones. Prostate Cancer Prostatic Dis. 2022. PMID: 36100698. doi:10.1038/s41391-022-00590-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。